Bausch Health Companies (BHC) Income towards Parent Company (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Income towards Parent Company came in at -$1.4 billion in Q1 2026, down 1563.95% year-on-year from $97.7 million in Q1 2025, and down 1289.32% quarter-over-quarter from -$103.0 million in Q4 2025.

Bausch Health Companies (BHC) Income towards Parent Company (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Income towards Parent Company across 18 years of filings, most recently posting -$1.4 billion for Q1 2026.

  • Income towards Parent Company for Q1 2026 came in at -$1.4 billion, down 1563.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 billion (down 1412.35% YoY), and the FY2025 annual result was $120.0 million, up 266.67% from the prior year.
  • Income towards Parent Company came in at -$1.4 billion for Q1 2026 at Bausch Health Companies, down from -$103.0 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $403.0 million in Q3 2022 to a low of -$1.4 billion in Q1 2026.
  • The 5-year median for Income towards Parent Company is -$77.0 million (2024), against an average of -$129.8 million.
  • Across the five-year window, Income towards Parent Company soared 12900.0% in 2025 and slumped 1563.95% in 2026, its largest moves.
  • Bausch Health Companies' Income towards Parent Company stood at -$410.0 million in 2022, then soared by 88.54% to -$47.0 million in 2023, then jumped by 308.51% to $98.0 million in 2024, then sank by 205.1% to -$103.0 million in 2025, then tumbled by 1289.32% to -$1.4 billion in 2026.
  • The last three Income towards Parent Company figures came in at -$1.4 billion (Q1 2026), -$103.0 million (Q4 2025), and $181.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn
10 Bausch Health Companies 1.92 Bn 1.58 Bn 2.48 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.43 Bn
Dec 31, 2025 -103.00 Mn
Sep 30, 2025 181.00 Mn
Jun 30, 2025 128.00 Mn
Mar 31, 2025 -86.00 Mn
Dec 31, 2024 98.00 Mn
Sep 30, 2024 -92.00 Mn
Jun 30, 2024 -1.00 Mn
Mar 31, 2024 -77.00 Mn
Dec 31, 2023 -47.00 Mn
Sep 30, 2023 -382.00 Mn
Jun 30, 2023 27.00 Mn
Mar 31, 2023 -209.00 Mn
Dec 31, 2022 -410.00 Mn
Sep 30, 2022 403.00 Mn
Jun 30, 2022 -139.00 Mn
Mar 31, 2022 -66.00 Mn
Dec 31, 2021 72.00 Mn
Sep 30, 2021 191.00 Mn
Jun 30, 2021 -669.00 Mn